+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Immunoassay Market by Product, Technology, Indication, End-user and Regional Outlook - Forecast to 2030

  • PDF Icon

    Report

  • 80 Pages
  • November 2023
  • Region: Global
  • IHR Insights
  • ID: 4846879
10% Free customization
Description Jump to:
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
A significant amount of secondary sources, directories, and databases were used in this market research study in order to locate and gather data relevant to this technical, financial, and market-oriented analysis of the worldwide biomarkers market. In order to gather and validate crucial qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were carried out with a variety of primary respondents, including important industry participants, subject-matter experts (SMEs), C-level executives of significant market players, and industry consultants, among other experts. To get the ultimate market size, the worldwide biomarkers market's size - which was approximated using a variety of secondary research techniques - was triangulated with data from primary research.

An immunoassay is a biochemistry-based test used to determine if an analyte is present or concentrated. A big protein or antibody that is created as a result of an infection can be an analyte. Immunoassays are now widely used and recognised laboratory protocols. They deliver exact and accurate results fast and effortlessly. The main applications of this approach are in food testing, drug discovery, clinical diagnostics, and drug monitoring.

The market was divided into a number of segments and sub-segments once the overall market size was determined utilising the market size estimation procedures. Data triangulation and market breakdown processes were used when appropriate to finish the entire market engineering process and obtain the precise statistics of each market segment and subsegment. By examining numerous variables and patterns from the immunoassays industry's supply and demand sides, the data was triangulated.

Immunoassay Market based on Technology:

  • ELISA
  • Fluorescence
  • Colorimetric
  • Chemiluminescence
  • Rapid Test
  • Western Blot
  • ELISPOT
  • PCR

Immunoassay Market based on Product & Service:

  • Reagents & Kits
  • Analyzers
  • Software Services

Immunoassay Market based on Application:

  • Infectious Disease
  • Endocrinology
  • Cardiology
  • Oncology
  • Hematology

Immunoassay Market based on End User:

  • Hospitals
  • Clinical Laboratories
  • Blood Banks
  • Academic Research Centers
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others

Immunoassay Market based on Geography:

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Latin America (LATAM)
  • Middle East and Africa (MEA)
The market for immunoassay has expanded significantly as a result of technology developments. For quicker testing and outcomes, automated laboratory apparatus has been designed. Labour and space requirements are decreased and laboratory efficiency is increased by automation. Because some players provide small, portable automated laboratory systems and point-of-care testing, the industry is growing quickly as a result.
Research laboratories, especially biotechnology labs, should catch up with their counterparts in diagnostics in terms of automated immunoassay implementation, and they should also become more familiar with the development of diagnostic apparatus. Every industry, including healthcare, is becoming more automated. Automated immunoassays, for example, offer increased assay transfer, reproducibility, and throughput.
Reduction in time and operator dependence on unpredictability are the two benefits of this method. In the US, Siemens Healthcare Diagnostic, for example, provides five completely automated immunoassay platforms.

In 2022, the immunoassay market was dominated by the kit and reagent category, which held a market share of over 61%. During the projected period, the sector is anticipated to lead the market. There is a growing need for immunoassay kits and reagents for diagnostic applications due to the rising incidence of autoimmune and infectious disorders. Additionally, immunoassay kit approval and distribution are anticipated to support segment expansion.

In 2022, the immunoassay market was dominated by the ELISA category, which held a market share of over 61%. This method has several advantages over immunoelectrophoretic and immunodiffusion, such as antiserum analysis, faster test periods, and qualitative and qualitative results.

The rising incidence of cancer cases around the world is the main reason boosting the immunoassay market over the predicted period. The International Agency for Research on Cancer projected that there will be over 18.2 million new cases of cancer worldwide in 2020, and that the disease will cause over 10 million deaths. Therefore, it is anticipated that a rise in cancer incidence will increase the use of immunoassays.

The immunoassay market is divided into end-user segments based on the following: blood banks, clinical labs, pharmaceutical & biotechnology firms, hospitals & clinics, research & academic laboratories, CROs, and home care settings. With a 31% market share in 2022, the hospital & clinical segment will have a dominant position in the immunoassay industry. The hospital segment is growing quickly as a result of the rise in hospital numbers.

Report Scope

  • This report illustrates the most vital attributes of the Immunoassay Market, which are driving and providing opportunities.
  • This research gives an in-depth analysis of the Immunoassay Market growth on the basis of several segments in the market.
  • This report presents the predictions of the past and present trends of the Biomarkers Market.
  • This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Immunoassay Market.

Table of Contents

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product Type: Market Size & Analysis
5.1. Overview
5.2. Consumables
5.3. Services
5.4. Software
6. Technology: Market Size & Analysis
6.1. Overview
6.2. Safety Biomarkers
6.3. Efficacy Biomarkers
6.4. Predictive Biomarkers
6.5. Surrogate Biomarkers
6.6. Pharmacodynamics Biomarkers
6.7. Prognostic Biomarkers
6.8. Validation Biomarkers
7. Product & Service: Market Size & Analysis
7.1. Overview
7.2. Safety Biomarkers
7.3. Efficacy Biomarkers
7.4. Predictive Biomarkers
7.5. Surrogate Biomarkers
7.6. Pharmacodynamics Biomarkers
7.7. Prognostic Biomarkers
7.8. Validation Biomarkers
8. Application: Market Size & Analysis
8.1. Overview
8.2. ELISA
8.3. Fluorescence
8.4. Colorimetric
8.5. Chemiluminescence
8.6. Rapid Test
8.7. Western Blot
8.8. ELISPOT
8.9. PCR
9. End user: Market Size & Analysis
9.1. Overview
9.2. Hospitals
9.3. Clinical Laboratories
9.4. Blood Banks
9.5. Academic Research Centers
9.6. Pharmaceutical Companies
9.7. Biotechnology Companies
9.8. Others
10. Geography: Market Size & Analysis
10.1. Overview
10.2. North America (U.S., Mexico, Canada)
10.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
10.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
10.5. Latin America (Brazil, Argentina)
10.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
11. Competitive Landscape
11.1. Competitor Comparison Analysis
11.2. Market Developments
11.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
11.2.2. Product Launches and execution
12. Vendor Profiles
12.1. Siemens Healthineers
12.1.1. Overview
12.1.2. Financial Overview
12.1.3. Product Offerings
12.1.4. Developments
12.1.5. Business Strategy
12.2. bioMérieux SA
12.2.1. Overview
12.2.2. Financial Overview
12.2.3. Product Offerings
12.2.4. Developments
12.2.5. Business Strategy
12.3. Abbott Laboratories
12.3.1. Overview
12.3.2. Financial Overview
12.3.3. Product Offerings
12.3.4. Developments
12.3.5. Business Strategy
12.4. Danaher Corporation (Beckman Coulter)
12.4.1. Overview
12.4.2. Financial Overview
12.4.3. Product Offerings
12.4.4. Developments
12.4.5. Business Strategy
12.5. Quidel Corporation
12.5.1. Overview
12.5.2. Financial Overview
12.5.3. Product Offerings
12.5.4. Developments
12.5.5. Business Strategy
12.6. Ortho Clinical Diagnostics
12.6.1. Overview
12.6.2. Financial Overview
12.6.3. Product Offerings
12.6.4. Developments
12.6.5. Business Strategy
12.7. Sysmex Corporation
12.7.1. Overview
12.7.2. Financial Overview
12.7.3. Product Offerings
12.7.4. Developments
12.7.5. Business Strategy
12.8. Bio-Rad Laboratories, Inc.
12.8.1. Overview
12.8.2. Financial Overview
12.8.3. Product Offerings
12.8.4. Developments
12.8.5. Business Strategy
12.9. F. Hoffmann-La Roche AG
12.9.1. Overview
12.9.2. Financial Overview
12.9.3. Product Offerings
12.9.4. Developments
12.9.5. Business Strategy
12.10. Thermo Fisher Scientific, Inc.
12.10.1. Overview
12.10.2. Financial Overview
12.10.3. Product Offerings
12.10.4. Developments
12.10.5. Business Strategy
13. Analyst Opinion
14. Annexure
14.1. Report Scope
14.2. Market Definitions
14.3. Research Methodology
14.3.1. Data Collation and In-house Estimation
14.3.2. Market Triangulation
14.3.3. Forecasting
14.4. Report Assumptions
14.5. Declarations
14.6. Stakeholders
14.7. Abbreviations
List of Tables
Table 1. Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 2. Immunoassay Market Value for Elisa, by Geography , 2021-2030 (USD Billion)
Table 3. Immunoassay Market Value for Fluorescence, by Geography, 2021-2030 (USD Billion)
Table 4. Immunoassay Market Value for Colorimetric, by Geography, 2021-2030 (USD Billion)
Table 5. Immunoassay Market Value for Chemiluminescence, by Geography, 2021-2030 (USD Billion)
Table 6. Immunoassay Market Value for Rapid Test, by Geography, 2021-2030 (USD Billion)
Table 7. Immunoassay Market Value for Western Blot, by Geography, 2021-2030 (USD Billion)
Table 8. Immunoassay Market Value for Elispot, by Geography, 2021-2030 (USD Billion)
Table 9. Immunoassay Market Value for Pcr, by Geography, 2021-2030 (USD Billion)
Table 10. Immunoassay Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 11. Immunoassay Market Value for Reagents & Kits, 2021-2030 (USD Billion)
Table 12. Immunoassay Market Value for Analyzers, by Geography, 2021-2030 (USD Billion)
Table 13. Immunoassay Market Value for Software Services, by Geography, 2021-2030 (USD Billion)
Table 14. Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 15. Immunoassay Market Value for Infectious Disease, 2021-2030 (USD Billion)
Table 16. Immunoassay Market Value for Endocrinology, by Geography, 2021-2030 (USD Billion)
Table 17. Immunoassay Market Value for Cardiology, by Geography, 2021-2030 (USD Billion)
Table 18. Immunoassay Market Value for Oncology, by Geography, 2021-2030 (USD Billion)
Table 19. Immunoassay Market Value for Hematology, by Geography, 2021-2030 (USD Billion)
Table 20. Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 21. Immunoassay Market Value for Hospitals, 2021-2030 (USD Billion)
Table 22. Immunoassay Market Value for Clinical Laboratories, by Geography, 2021-2030 (USD Billion)
Table 23. Immunoassay Market Value for Blood Banks, by Geography, 2021-2030 (USD Billion)
Table 24. Immunoassay Market Value for Academic Research Centers, by Geography, 2021-2030 (USD Billion)
Table 25. Immunoassay Market Value for Pharmaceutical Companies, by Geography, 2021-2030 (USD Billion)
Table 26. Immunoassay Market Value for Biotechnology Companies, by Geography, 2021-2030 (USD Billion)
Table 27. Immunoassay Market Value for Others, by Geography, 2021-2030 (USD Billion)
Table 28. North America Immunoassay Market Value, by Country, 2021-2030 (USD Billion)
Table 29. North America Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 30. North America Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 31. North America Immunoassay Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 32. North America Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 33. North America Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 34. U.S Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 35. U.S Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 36. U.S Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 37. U.S Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 38. Canada Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 39. Canada Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 40. Canada Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 41. Canada Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 42. Mexico Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 43. Mexico Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 44. Mexico Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 45. Mexico Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 46. Europe Immunoassay Market Value, by Country, 2021-2030 (USD Billion)
Table 47. Europe Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 48. Europe Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 49. Europe Immunoassay Market Value, End Use Industries, 2021-2030 (USD Billion)
Table 50. Europe Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 51. Germany Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 52. Germany Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 53. Germany Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 54. Germany Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 55. U.K Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 56. U.K Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 57. U.K Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 58. U.K Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 59. France Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 60. France Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 61. France Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 62. France Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 63. Italy Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 64. Italy Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 65. Italy Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 66. Italy Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 67. Spain Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 68. Spain Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 69. Spain Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 70. Spain Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 71. RoE Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 72. RoE Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 73. RoE Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 74. RoE Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 75. Asia-Pacific Immunoassay Market Value, by Country, 2021-2030 (USD Billion)
Table 76. Asia-Pacific Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 77. Asia-Pacific Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 78. Asia-Pacific Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 79. Asia-Pacific Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 80. China Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 81. China Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 82. China Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 83. China Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 84. India Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 85. India Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 86. India Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 87. India Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 88. Japan Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 89. Japan Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 90. Japan Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 91. Japan Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 92. Rest of APAC Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 93. Rest of APAC Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 94. Rest of APAC Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 95. Rest of APAC Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 96. Latin America Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 97. Latin America Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 98. Latin America Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 99. Latin America Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 100. Brazil Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 101. Brazil Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 102. Brazil Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 103. Brazil Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 104. Argentina Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 105. Argentina Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 106. Argentina Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 107. Argentina Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 108. Middle East and Africa Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 109. Middle East and Africa Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 110. Middle East and Africa Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 111. Middle East and Africa Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 112. Saudi Arabia Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 113. Saudi Arabia Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 114. Saudi Arabia Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 115. Saudi Arabia Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 116. UAE Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 117. UAE Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 118. UAE Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 119. UAE Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 120. Rest of Middle East and Africa Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Table 121. Rest of Middle East and Africa Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Table 122. Rest of Middle East and Africa Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Table 123. Rest of Middle East and Africa Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Table 124. Siemens Healthineers: Financials
Table 125. Siemens Healthineers: Products & Services
Table 126. Siemens Healthineers: Recent Developments
Table 127. Biomérieux SA: Financials
Table 128. Biomérieux SA: Products & Services
Table 129. Biomérieux SA: Recent Developments
Table 130. Abbott Laboratories: Financials
Table 131. Abbott Laboratories: Products & Services
Table 132. Abbott Laboratories: Recent Developments
Table 133. Danaher Corporation (Beckman Coulter).: Financials
Table 134. Danaher Corporation (Beckman Coulter).: Products & Services
Table 135. Danaher Corporation (Beckman Coulter).: Recent Developments
Table 136. Quidel Corporation: Financials
Table 137. Quidel Corporation: Products & Services
Table 138. Quidel Corporation: Recent Developments
Table 139. Ortho Clinical Diagnostics: Financials
Table 140. Ortho Clinical Diagnostics: Products & Services
Table 141. Ortho Clinical Diagnostics: Recent Developments
Table 142. Sysmex Corporation: Financials
Table 143. Sysmex Corporation: Products & Services
Table 144. Sysmex Corporation: Developments
Table 145. Bio-Rad Laboratories, Inc.: Financials
Table 146. Bio-Rad Laboratories, Inc.: Products & Services
Table 147. Bio-Rad Laboratories, Inc.: Recent Developments
Table 148. F. Hoffmann-La Roche AG: Financials
Table 149. F. Hoffmann-La Roche AG: Products & Services
Table 150. F. Hoffmann-La Roche AG: Recent Developments
Table 151. Thermo Fisher Scientific, Inc.: Financials
Table 152. Thermo Fisher Scientific, Inc.: Products & Services
Table 153. Thermo Fisher Scientific, Inc.: Recent Developments
List of Charts
Chart. 1. Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 2. Immunoassay Market Value for Elisa, by Geography , 2021-2030 (USD Billion)
Chart. 3. Immunoassay Market Value for Fluorescence, by Geography, 2021-2030 (USD Billion)
Chart. 4. Immunoassay Market Value for Colorimetric, by Geography, 2021-2030 (USD Billion)
Chart. 5. Immunoassay Market Value for Chemiluminescence, by Geography, 2021-2030 (USD Billion)
Chart. 6. Immunoassay Market Value for Rapid Test, by Geography, 2021-2030 (USD Billion)
Chart. 7. Immunoassay Market Value for Western Blot, by Geography, 2021-2030 (USD Billion)
Chart. 8. Immunoassay Market Value for Elispot, by Geography, 2021-2030 (USD Billion)
Chart. 9. Immunoassay Market Value for Pcr, by Geography, 2021-2030 (USD Billion)
Chart. 10. Immunoassay Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 11. Immunoassay Market Value for Reagents & Kits, 2021-2030 (USD Billion)
Chart. 12. Immunoassay Market Value for Analyzers, by Geography, 2021-2030 (USD Billion)
Chart. 13. Immunoassay Market Value for Software Services, by Geography, 2021-2030 (USD Billion)
Chart. 14. Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 15. Immunoassay Market Value for Infectious Disease, 2021-2030 (USD Billion)
Chart. 16. Immunoassay Market Value for Endocrinology, by Geography, 2021-2030 (USD Billion)
Chart. 17. Immunoassay Market Value for Cardiology, by Geography, 2021-2030 (USD Billion)
Chart. 18. Immunoassay Market Value for Oncology, by Geography, 2021-2030 (USD Billion)
Chart. 19. Immunoassay Market Value for Hematology, by Geography, 2021-2030 (USD Billion)
Chart. 20. Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 21. Immunoassay Market Value for Hospitals, 2021-2030 (USD Billion)
Chart. 22. Immunoassay Market Value for Clinical Laboratories, by Geography, 2021-2030 (USD Billion)
Chart. 23. Immunoassay Market Value for Blood Banks, by Geography, 2021-2030 (USD Billion)
Chart. 24. Immunoassay Market Value for Academic Research Centers, by Geography, 2021-2030 (USD Billion)
Chart. 25. Immunoassay Market Value for Pharmaceutical Companies, by Geography, 2021-2030 (USD Billion)
Chart. 26. Immunoassay Market Value for Biotechnology Companies, by Geography, 2021-2030 (USD Billion)
Chart. 27. Immunoassay Market Value for Others, by Geography, 2021-2030 (USD Billion)
Chart. 28. North America Immunoassay Market Value, by Country, 2021-2030 (USD Billion)
Chart. 29. North America Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 30. North America Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 31. North America Immunoassay Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 32. North America Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 33. North America Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 34. U.S Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 35. U.S Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 36. U.S Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 37. U.S Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 38. Canada Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 39. Canada Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 40. Canada Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 41. Canada Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 42. Mexico Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 43. Mexico Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 44. Mexico Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 45. Mexico Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 46. Europe Immunoassay Market Value, by Country, 2021-2030 (USD Billion)
Chart. 47. Europe Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 48. Europe Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 49. Europe Immunoassay Market Value, End Use Industries, 2021-2030 (USD Billion)
Chart. 50. Europe Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 51. Germany Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 52. Germany Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 53. Germany Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 54. Germany Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 55. U.K Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 56. U.K Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 57. U.K Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 58. U.K Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 59. France Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 60. France Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 61. France Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 62. France Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 63. Italy Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 64. Italy Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 65. Italy Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 66. Italy Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 67. Spain Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 68. Spain Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 69. Spain Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 70. Spain Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 71. RoE Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 72. RoE Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 73. RoE Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 74. RoE Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 75. Asia-Pacific Immunoassay Market Value, by Country, 2021-2030 (USD Billion)
Chart. 76. Asia-Pacific Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 77. Asia-Pacific Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 78. Asia-Pacific Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 79. Asia-Pacific Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 80. China Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 81. China Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 82. China Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 83. China Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 84. India Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 85. India Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 86. India Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 87. India Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 88. Japan Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 89. Japan Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 90. Japan Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 91. Japan Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 92. Rest of APAC Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 93. Rest of APAC Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 94. Rest of APAC Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 95. Rest of APAC Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 96. Latin America Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 97. Latin America Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 98. Latin America Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 99. Latin America Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 100. Brazil Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 101. Brazil Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 102. Brazil Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 103. Brazil Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 104. Argentina Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 105. Argentina Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 106. Argentina Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 107. Argentina Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 108. Middle East and Africa Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 109. Middle East and Africa Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 110. Middle East and Africa Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 111. Middle East and Africa Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 112. Saudi Arabia Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 113. Saudi Arabia Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 114. Saudi Arabia Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 115. Saudi Arabia Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 116. UAE Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 117. UAE Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 118. UAE Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 119. UAE Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 120. Rest of Middle East and Africa Immunoassay Market Value, by Product, 2021-2030 (USD Billion)
Chart. 121. Rest of Middle East and Africa Immunoassay Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 122. Rest of Middle East and Africa Immunoassay Market Value, by Application, 2021-2030 (USD Billion)
Chart. 123. Rest of Middle East and Africa Immunoassay Market Value, by End-user, 2021-2030 (USD Billion)
Chart. 124. Siemens Healthineers: Financials
Chart. 125. Siemens Healthineers: Products & Services
Chart. 126. Siemens Healthineers: Recent Developments
Chart. 127. Biomérieux SA: Financials
Chart. 128. Biomérieux SA: Products & Services
Chart. 129. Biomérieux SA: Recent Developments
Chart. 130. Abbott Laboratories: Financials
Chart. 131. Abbott Laboratories: Products & Services
Chart. 132. Abbott Laboratories: Recent Developments
Chart. 133. Danaher Corporation (Beckman Coulter).: Financials
Chart. 134. Danaher Corporation (Beckman Coulter).: Products & Services
Chart. 135. Danaher Corporation (Beckman Coulter).: Recent Developments
Chart. 136. Quidel Corporation: Financials
Chart. 137. Quidel Corporation: Products & Services
Chart. 138. Quidel Corporation: Recent Developments
Chart. 139. Ortho Clinical Diagnostics: Financials
Chart. 140. Ortho Clinical Diagnostics: Products & Services
Chart. 141. Ortho Clinical Diagnostics: Recent Developments
Chart. 142. Sysmex Corporation: Financials
Chart. 143. Sysmex Corporation: Products & Services
Chart. 144. Sysmex Corporation: Developments
Chart. 145. Bio-Rad Laboratories, Inc.: Financials
Chart. 146. Bio-Rad Laboratories, Inc.: Products & Services
Chart. 147. Bio-Rad Laboratories, Inc.: Recent Developments
Chart. 148. F. Hoffmann-La Roche AG: Financials
Chart. 149. F. Hoffmann-La Roche AG: Products & Services
Chart. 150. F. Hoffmann-La Roche AG: Recent Developments
Chart. 151. Thermo Fisher Scientific, Inc.: Financials
Chart. 152. Thermo Fisher Scientific, Inc.: Products & Services
Chart. 153. Thermo Fisher Scientific, Inc.: Recent Developments

Companies Mentioned

  • Siemens Healthineers
  • bioMérieux SA
  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter)
  • Quidel Corporation
  • Ortho Clinical Diagnostics
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.

Related Topics

Related Reports

Microfluidic Immunoassay Market by Product, Technology, Application, and End User - Global Forecast to 2030 - Product Image

Microfluidic Immunoassay Market by Product, Technology, Application, and End User - Global Forecast to 2030

  • Report
  • 269 Pages
  • Global
From
Global Chemiluminescence Immunoassay Market by Product (Instrument, Consumable), Technology (Chemiluminescence Enzyme, Microparticle Chemiluminescence), Sample (Blood, Urine), Application (Infectious Disease, Oncology), End User - Forecast to 2028 - Product Image

Global Chemiluminescence Immunoassay Market by Product (Instrument, Consumable), Technology (Chemiluminescence Enzyme, Microparticle Chemiluminescence), Sample (Blood, Urine), Application (Infectious Disease, Oncology), End User - Forecast to 2028

  • Report
  • Global
From
Chemiluminescence Immunoassay Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

Chemiluminescence Immunoassay Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 255 Pages
  • Global
From
In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry, Molecular Diagnostic, Microbiology, Hematology) Use (Clinical, RUO) End User - Global Forecast to 2030 - Product Image

In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry, Molecular Diagnostic, Microbiology, Hematology) Use (Clinical, RUO) End User - Global Forecast to 2030

  • Report
  • 389 Pages
  • Global
From
Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Rapid Tests), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Blood Banks) & Region - Global Forecast to 2028 - Product Image

Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Rapid Tests), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Blood Banks) & Region - Global Forecast to 2028

  • Report
  • 382 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.